BIO Protocol is a blockchain-based platform designed to innovate how biotechnology is funded, developed, and owned. It operates within the Decentralized Science (DeSci) ecosystem, enabling communities of scientists, patients, and biotech professionals to collaboratively fund and manage tokenized biotech projects and intellectual property (IP). By leveraging blockchain technology and decentralized autonomous organizations (DAOs), BIO Protocol aims to make biotech innovation more inclusive and transparent, bridging gaps in traditional funding models.
BIO Protocol supports biotech innovation through decentralized funding, tokenized intellectual property, and community-driven governance. BioDAOs—decentralized organizations focused on specific research areas—pool resources to fund and develop biotech projects, creating shared ownership of the resulting IP. The BIO Launchpad helps BioDAOs through curation (community voting), acceleration (fundraising via auctions or bonding curves), and separation (market entry with liquidity support). Intellectual Property Tokens (IPTs) further democratize biotech ownership by enabling fractional governance rights over scientific breakthroughs.
BIO Protocol was co-founded by Paul Kohlhaas, a blockchain innovator with a background in decentralized science. Kohlhaas also co-founded Molecule, a platform for tokenizing biomedicine projects, and VitaDAO, focused on longevity research.
BIO is the native governance token of the BIO protocol. With a total supply of 3,320,000,000 tokens, it serves multiple purposes within the BIO Protocol ecosystem
As BIO Protocol has not launched its token yet, its investment potential is speculative. Factors like its focus on decentralized biotech, token utility, and community-driven governance could appeal to investors, but risks include market volatility and adoption challenges. Research thoroughly before considering involvement.
Buy BIO Protocol in Trinidad & Tobago with Bitget